Table 2.
The 26 KEGG pathways associated with the putative targets of Qingdai.
| Term | Count | P-value |
|---|---|---|
| hsa04914: Progesterone-mediated oocyte maturation | 10 | 2.93E-07 |
| hsa04080: Neuroactive ligand-receptor interaction | 13 | 1.57E-05 |
| hsa04115: p53 signaling pathway | 7 | 8.78E-05 |
| hsa04060: Cytokine-cytokine receptor interaction | 12 | 1.03E-04 |
| hsa04110: Cell cycle | 8 | 3.91E-04 |
| hsa04510: Focal adhesion | 9 | 0.001437085 |
| hsa05210: Colorectal cancer | 6 | 0.002152457 |
| hsa05200: Pathways in cancer | 11 | 0.002692876 |
| hsa04062: Chemokine signaling pathway | 8 | 0.004097191 |
| hsa04621: NOD-like receptor signaling pathway | 5 | 0.004583166 |
| hsa04620: Toll-like receptor signaling pathway | 6 | 0.004793465 |
| hsa05120: Epithelial cell signaling in Helicobacter pylori infection | 5 | 0.006372769 |
| hsa04622: RIG-I-like receptor signaling pathway | 5 | 0.00742055 |
| hsa05212: Pancreatic cancer | 5 | 0.007793627 |
| hsa04664: Fc epsilon RI signaling pathway | 5 | 0.010293415 |
| hsa04722: Neurotrophin signaling pathway | 6 | 0.011255823 |
| hsa04020: Calcium signaling pathway | 7 | 0.012206329 |
| hsa05215: Prostate cancer | 5 | 0.016120746 |
| hsa04912: GnRH signaling pathway | 5 | 0.022181176 |
| hsa04010: MAPK signaling pathway | 8 | 0.026015669 |
| hsa04660: T cell receptor signaling pathway | 5 | 0.030365615 |
| hsa05214: Glioma | 4 | 0.03155056 |
| hsa04114: Oocyte meiosis | 5 | 0.032191066 |
| hsa05218: Melanoma | 4 | 0.042714992 |
| hsa04012: ErbB signaling pathway | 4 | 0.040141341 |
| hsa04930: Type II diabetes mellitus | 3 | 0.034045303 |